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The urgent challenges 
we now face in 
health can only be 
met by intelligent, 
co‑ordinated 
responses, informed 
by applied research 
that builds the 
evidence base 
for effective health 
practice focused 
on public need.” 
Our continent is 
developing rapidly. We 
are making significant 
progress in controlling 
infectious diseases, 
and meeting old and 
new challenges by 
investing in our health, 
research and science 
infrastructure, with the 
support of funders and 
partners globally.”
  In 2009, the School became the 
first academic institution in the 
world to be awarded the Gates 
Award for Global Health by the 
Global Health Council
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Foreword
Although more of the world’s seven billion people are living longer and healthier lives 
than ever, we face many urgent challenges. The inexorable tide of non-communicable 
diseases, the emergence of antibiotic-resistance, the threat of new pandemics, and the 
health impacts of conflict and climate change, are all ‘wicked problems’ that impose 
severe burdens on health services, systems and societies, locally and globally.
The School’s mission is to help address these challenges, through our research, 
education and innovation. To achieve this, we work collaboratively with hundreds of 
partners all over the world, ranging from governments and international agencies to 
local clinics and community groups.
This report provides a brief overview of the School’s recent work, and a glimpse of 
the future. It has been a year of healthy growth across all areas of activity, and many 
achievements by individuals and the School as a whole. For example, our postgraduate 
programmes – both London-based and distance learning – were commended by the 
UK’s Quality Assurance Agency for Higher Education, and in October the School was 
named by the compilers of a global league table as the world’s leading research-
focused graduate school – which reflects the growing recognition our work is receiving.
I hope you will take a few minutes to read this review, and that you find it enjoyable 
and inspiring.
Sir Tim Lankester, Chair of Council
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Our vision is to be a 
world‑leading school of public 
and global health, working 
closely with partners in the 
UK and worldwide to address 
contemporary and future 
critical health challenges.
Our mission is to improve 
health and health equity in 
the UK and worldwide; working 
in partnership to achieve 
excellence in public and global 
health research, education 
and translation of knowledge 
into policy and practice.
Professor Dame Sally Davies
Chief Medical Officer, the 
UK Government’s principal 
medical adviser and Chief 
Scientific Adviser for the 
Department of Health
Dr Tedros Ghebreyesus
Foreign Minister and former 
Minister of Health, Ethiopia; 
Alumnus and Honorary 
Fellow of the School
With the National Institute for Health Research, Policy Research Units, 
and other partnerships, we are developing a research infrastructure that 
taps into world-class academic resources, and the London School of 
Hygiene & Tropical Medicine is a key partner in these initiatives. 
Through its collaborative work with the National Health Service, Public 
Health England, National Institute for Health and Care Excellence, local 
government and NGOs, the School is making many vital contributions 
to public health, from laboratory research in infectious diseases to 
advising on implementation of interventions, and health service and 
policy evaluations.
The London School of Hygiene & Tropical Medicine is a key partner 
in this work, and is helping national and local governments, universities 
and hospitals strengthen their research and capacity, and exchange 
knowledge and expertise.
I am honoured to be associated with this world-leading institution, 
and I know from personal experience how dedicated the School’s staff, 
students and alumni are – conducting research and taking practical 
action that saves lives and improves health worldwide.
World no. 1 research‑
focused graduate school
In 2013, the School was named 
the world’s top research-focused 
graduate school in the Times 
Higher Education world rankings.
Click on the contents to 
jump to the page you want
Active web addresses, links 
and emails are underlined.
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A
s a postgraduate and research 
institution we are not included 
in most university league tables. 
However, this year the School was 
named the world’s ‘leading research-
focused graduate school’ by Thomson 
Reuters and Times Higher Education. 
As well as achieving the best overall score, 
coming top of a table ahead of elite global 
institutions, we were ranked particularly 
highly for indicators including international 
outlook, research and citations.
Impact is long-term and notoriously hard 
to measure. This year, the new Research 
Excellence Framework has required us to 
evaluate and document the wider societal 
benefits of our work. Although the process 
has been time-consuming, it is a good 
discipline for academics to assess and 
communicate the many benefits of our work, 
as it is only by so doing that we can win 
wider public understanding and support, 
as well as sustained funding. 
In October this year, I attended a centennial 
anniversary celebration for the UK Medical 
Research Council at the Royal Society, at 
which School researchers Austin Bradford Hill, 
Jerry Morris and Brian Greenwood were among 
distinguished MRC-supported scientists of 
the past 100 years. This highlighted how 
we have contributed to the excellence of 
British science, and thanks to the quality 
and enterprise of our staff, research at the 
School continues to flourish and grow.
While our ability to attract funding and 
the best staff and students is vital, these 
outcomes cannot be ends in themselves. 
Our success is rightly measured by the 
outcomes of our research, teaching, 
knowledge transfer and capacity-building 
activities, and the positive impacts 
of these on society and people’s lives.
Evidence of such outcomes is manifold: 
around two thousand papers written or 
co-authored by staff and research students 
over the year, with significant findings ranging 
from new discoveries in pathogen molecular 
biology, to vaccine development, water 
quality and child health, cancer survival, 
HIV and tuberculosis interactions, transport 
and health, health services reform, medical 
tourism and sexual attitudes. As well as 
being widely cited in high-impact journals, 
many of these findings have achieved 
global media coverage.
Professor Baron Peter Piot, Director 
Our students have continued to excel 
academically and on graduating, to secure 
excellent jobs and placements in their chosen 
fields. We strengthened our many partnerships 
worldwide and established new links, joint 
appointments and courses, notably in China, 
South East Asia, India and throughout Africa.
In London, we joined UCLPartners, contributing 
to the successful bid for a new Academic 
Health Sciences Centre, and continued to 
work with University College London on the 
development of the Bloomsbury Research 
Institute as a world-leading centre for 
infectious diseases. Our knowledge transfer 
and innovation activity resulted in the 
development of new diagnostic tools and 
the launch of our commercialisation vehicle, 
Chariot Innovations Limited.
In October, the Oxford Martin Commission for 
Future Generations, of which I am a member, 
launched its report entitled Now for the 
Long Term. This calls for governments and 
institutions to abandon short-termism, address 
deep persisting inequalities, and shift priorities 
towards longer-term challenges that will shape 
our futures – hopefully a commitment which will 
also be a main theme of the post-2015 agenda 
for sustainable development. Translating such 
long-term vision into daily practice is very 
challenging, but vital if we are to avert the 
deep and complex crises we now face.
As a society we underestimate the scale of 
challenges such as the impacts of climate 
and demographic change, migration and 
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Making an impact: now and for the long term
Peter Piot, Director
globalisation, the threat of antibiotics and 
emerging epidemics, over-consumption and 
the tsunami of chronic diseases. All health 
systems are now struggling: they are facing 
new demographic, disease and technological 
challenges which leave them overburdened 
and riddled with structural inefficiencies 
and perverse incentives. We have to reform, 
innovate and work far more ‘upstream’, 
scaling up prevention and public health 
policy solutions.
Above all, we must resist the fatalistic 
attitude that ‘nothing can be done’ about the 
big challenges. We need evidence-informed 
optimism to persistently ask better questions 
and find better answers. This effort requires 
political science and economics as well as 
basic science, patient care and epidemiology, 
speaking truth to power, encouraging and 
enabling our leaders to think and act for 
the long term.
Honours and awards 2013
·  Anne Mills elected Fellow of the 
Royal Society.
·  Polly Roy and Brendan Wren receive 
Wellcome Trust senior investigator 
awards, and Alex Mold wins junior 
investigator award.
·   Neil Pearce, Andrew Prentice and 
Anthony Scott elected Fellows of 
the Academy of Medical Sciences.
·   Andy Hall received a knighthood in the 
Queen’s birthday honours’ list.
·  Clare Gilbert wins Pisart Vision Award 
in recognition of her work on prevention 
of childhood blindness.
·   Nick Black awarded a Career Achievement 
Prize in recognition of his contribution 
to advancing the use of patient reported 
outcome measures and along with Ben 
Goldacre, named in the inaugural Clinical 
Leaders list by Health Service Journal.
·   Peter Piot 
awarded the 
Hideyo Noguchi 
Africa Prize 
for Medical 
Research 
by Japan’s 
Prime Minister 
Shinzo Abe 
(right).
Professor Piot taking part in BBC world service 
panel as part of the inaugural Africa Science 
Festival in Kampala
This year, the School 
was named the  
world’s leading research-
focused graduate school  
by Thomson Reuters and  
Times Higher Education”
Professor Peter Piot
Income from research grants increased 
over 10% this year to £79 million, as set 
out in on page 23. Of this total, UK, EU 
and US government departments and 
agencies contributed nearly half of this total, 
with another 45% coming from charitable 
sources, including the Wellcome Trust and 
the Bill & Melinda Gates Foundation.
This year, we received an excellent report 
on the quality of our education programmes 
from the UK Quality Assurance Agency, and 
in the autumn achieved a significant increase 
in student enrolments, with numbers of 
London-based students 14% up on last 
year, reversing a dip in 2012.
Our students 
have continued 
to excel academically 
and on graduating, to 
secure excellent jobs 
and placements in 
their chosen fields” 
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Breakthrough on meningococcal meningitis vaccine
Results published in September 2013 showed that vaccination of almost 2 million people in 
Chad led to a dramatic reduction in the incidence of all cases of meningitis by 94% and in 
carriage prevalence of the epidemic strain, serogroup A meningitis, by 98%, while an epidemic 
persisted in unvaccinated parts of the country. The African Meningococcal Carriage Consortium 
(MenAfriCar), led by Brian Greenwood and funded by the Wellcome Trust and Bill & Melinda Gates 
Foundation, is investigating the patterns of meningitis and trialling the introduction of the new 
MenAfriVac vaccine in Chad, Senegal, Mali, Ghana, Niger and Nigeria.
West and Central Africa
 Medical Research Council Gambia Unit
 Centre MURAZ – Burkina Faso
GENINVADE Project – parasite population 
genomics and functional studies
Programme for improving mental 
health care (PRIME)
Improving the evidence 
base on disability
IDEAS for maternal and 
newborn health
Radio health messages 
to reduce child mortality 
Community‑based 
prevention of non‑
communicable diseases
Southern Africa
Youth‑friendly health services 
– HIV prevention clinics
Zambia AIDS related 
tuberculosis project 
(ZAMBART)
Sport and HIV prevention
Human papillomavirus in Africa research 
partnership (HARP)
Zimbabwe study for enhancing testing 
and improving treatment of HIV in 
children (ZENITH)
CONCORD Programme – surveillance 
of cancer survival
Nutritional support for Africans starting 
antiretroviral therapy (NUSTART)
VISION 2020 Links Programme – eye health
T
hanks to painstaking medical research over the past few decades, millions of lives 
have been saved and health improved across Africa, but millions more people continue 
to suffer and die from preventable and treatable conditions: not only malaria, AIDS 
and tuberculosis, but undernutrition, diarrhoea, the complications of childbirth and, 
increasingly, hypertension, diabetes, cancer and cardiovascular diseases. We are also 
confronted by the emerging threats of new infections and pandemics. The School is engaged in 
collaborative research and teaching with many partners across the region. These links have been 
further enhanced by our participation in a growing number of international research consortia, 
which strengthen the capacity of African institutions to carry out world-class research.
Trachoma mapping and treatment
Blinding trachoma affects more 
than 21 million people globally, 
with up to 180 million at risk in 
the world’s poorest countries. The 
Global Trachoma Mapping Project 
is a consortium of ministries of 
health, NGOs and academic partners 
worldwide, funded by UK Department 
for International Development. School 
researcher Anthony Solomon, chief 
scientist for the project, is training 
teams to use smart phones to collect 
data on water, sanitation and hygiene, 
and examining people for clinical 
evidence of trachoma in countries 
including Guinea Bissau, Cameroon 
and Nigeria. Researchers from the 
School’s International Centre for 
Eye Health are also working with 
hospitals across Africa as part of 
the VISION 2020 Links Programme, 
a global initiative to eliminate 
avoidable blindness worldwide.
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Malawi Epidemiology and 
Intervention Research Unit
The Karonga Prevention Study was established 
in Malawi in 1979, and has since expanded 
to include tuberculosis, HIV, demography, 
and most recently, cardiovascular disease 
and diabetes, as the epidemic of non-
communicable diseases spreads across 
Africa. Today, a uniquely detailed database 
links work over more than three decades on 
around 300,000 people. A new site recently 
opened in Lilongwe, and the combined 
programme has been brought together as 
the Malawi Epidemiology and Intervention 
Research Unit (MEIRU), with Professor Moffat 
Nyirenda appointed director in July 2013.
Protecting children through 
Seasonal Malaria Chemoprevention
Work by School researchers and partners in 
Senegal, Mali, Burkina Faso, Gambia and Ghana 
over the past decade has led to the introduction 
of a new prevention strategy known as Seasonal 
Malaria Chemoprevention. Children without 
symptoms of malaria receive a dose of an 
anti-malarial drug combination once a month 
during the high malaria transmission season. 
In 2012/13, this was incorporated in World 
Health Organization guidelines, and the 
programme extended to Chad, Niger and Nigeria.
ALPHA network: population‑based 
HIV data
A vast amount of data is available on various 
aspects of health in Africa, but it can often be 
difficult to compare studies. The network for 
Analysis of Longitudinal Population-based HIV 
data in Africa (ALPHA) is working to improve the 
usefulness of data generated in community-
based cohort studies on HIV in sub-Saharan 
Africa by combining data sets into a common 
format. The network is co-ordinated by Basia 
Zaba and Jim Todd at the School, advised by 
WHO, UNAIDS and partners in Kenya, Malawi, 
South Africa, Tanzania, Uganda and Zimbabwe.
In 2013, they published results which found 
an estimated 24% of pregnancy-related deaths 
in sub-Saharan Africa are attributable to HIV, 
and that HIV positive pregnant and post-partum 
women are eight times more likely to die than 
their HIV negative counterparts.
Antiretroviral Therapy to 
cut HIV Transmission
Can timely treatment for HIV also serve to 
reduce transmission at population level? 
A major trial is now underway to test a new 
approach to the prevention and control of AIDS 
in Africa. The Population effect of Antiretroviral 
therapy to Reduce HIV Transmission study 
led by Richard Hayes, known as PopART 
HPTN 071, involves 21 communities with 
a total population of 1.2 million in South 
Africa and Zambia. 
This new test-and-treat approach encourages 
and supports the entire community to test 
for HIV, and offers immediate treatment with 
anti-HIV drugs to everyone who is HIV-positive. 
This enables HIV-positive individuals to be 
diagnosed at a much earlier stage, which 
should protect the health of HIV-infected 
patients at the same time as steeply 
reducing the number of new infections.
Safety of malaria drugs
Artemisinin-based combination therapy is the 
first line recommended treatment for malaria. 
Although it is highly effective, there are many 
issues around access, safety, targeting and 
drug quality. The ACT Consortium, with its 
secretariat based at the School, is a global 
research collaboration that addresses these 
issues through 25 studies in 10 countries.
Capacity strengthening consortia 
1   Artemisinin Combination Therapy (ACT) Consortium
2   Consortium for health policy & systems analysis in 
Africa (CHEPSAA)
3   Malaria capacity development consortium (MCDC)
4   South African consortia research for 
excellence (SACORE)
5   Southern African centre for infectious disease 
surveillance (SACIDS)
6   Tackling the structural drivers of HIV (STRIVE)
7   Training health researchers into vocational 
excellence in East Africa (THRiVE)
8   African SNOWS Consortium: Scientists Networked 
for Outcomes from Water and Sanitation
9   African Meningococcal Carriage 
Consortium (ManAfriCar)
East Africa
National Institute for 
Medical Research / 
Mwanza Intervention 
Trials Unit
Human papillomavirus 
vaccine trials –  
sub‑Saharan Africa
Program for resistance, 
immunology, surveillance 
and monitoring (PRISM)
 Good School Toolkit to prevent 
violence against children
 Treating child sickle cell disease
 Improving newborn survival in southern 
Tanzania (INSIST)
 Treatment of HIV‑positive patients with 
visceral leishmaniasis
 Ciclosporin in leprosy reactions clinical trial
These pages show just a few of more than 50 projects and partnerships across 
Africa. For more details, please read our 2013 regional publications. These 
are available on our website, as well as a searchable map of our work in over 
100 countries worldwide www. lshtm.ac.uk/aboutus/introducing/map
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Selected projects and partnerships
Improving health systems, 
services and policy
In recent years, School researchers have 
been conducting pioneering research on 
health economics and health policy change. 
The Consortium for Health Policy and Systems 
Analysis in Africa, led by Lucy Gilson, joint 
professor with the University of Cape Town, 
is a partnership of seven universities in 
Africa and four in Europe. Kara Hanson, Lucy 
Gilson and colleagues are also working in 
seven countries across Africa and Asia in the 
Resilient and Responsive Health Systems 
research programme to improve governance, 
human resources and financing.
The GOAL Trial is examining the effectiveness of 
the Generation Skillz programme for reducing risk 
behaviour among 15–18 year old boys and girls in 
Cape Town and Port Elizabeth
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School Centres
Bloomsbury Centre for Genetic Epidemiology & Statistics  
Advances the understanding of the genetic mechanisms underlying 
health and disease through the development and application of 
computational tools and quantitative methods and models. 
Centre for Evaluation  
Improves the design and conduct of public health evaluations 
through the development, application and dissemination of rigorous 
methods, and facilitates the use of robust evidence to inform policy 
and practice decisions.
Centre for Global Mental Health  
Fosters research, capacity building and advocacy in prevention, 
treatment and care, with the ultimate objective of reducing the 
global burden of mental, neurological and substance use disorders.
Centre for Global Non‑Communicable Diseases  
Strengthens and promotes research, training and international 
networking in non-communicable disease research and health policy.
Centre for History in Public Health  
Promotes and undertakes high quality research in order to contribute 
to the development of the historical discipline and to historical 
understanding in the field of public health policy.
MARCH Centre for Maternal, Adolescent, 
Reproductive & Child Health  
Improves health for adolescents, women, newborns and children 
through better numbers and evidence, leadership development, 
and active policy engagement.
Centre for the Mathematical Modelling of Infectious Diseases  
Uses models to understand and predict the spread of infectious 
diseases and to test and guide interventions.
Centre for Statistical Methodology  
Enhances methodological cross-fertilisation among public 
health researchers.
Centre for Tuberculosis (TB Centre)  
Provides a focus for the School’s long-established global research 
expertise in tuberculosis epidemiology, immunology, diagnosis 
and treatment.
European Centre on Health of Societies in Transition ECOHOST  
Research into diverse aspects of health and health care arising 
from social, political and economic transformation.
International Centre for Evidence on Disability  
Improves health and well-being among people with disabilities 
through excellence in research, teaching and knowledge translation.
International Diagnostics Centre 
Facilitates the development, evaluation and implementation of 
accessible, quality assured in-vitro diagnostics for global health 
through information sharing and advocacy.
Malaria Centre  
Provides evidence for policy and practice in the prevention, 
diagnosis and treatment of malaria around the world.
Vaccine Centre 
Research from antigen discovery to the evaluation of vaccine 
effectiveness, policy and advocacy.
76
S
ince 2012 we have held an annual 
School symposium to bring all 
staff together, including those 
based overseas. In 2013 the 
theme was ‘Achieving impact’; 
we showcased good practice within the 
School and discussed how to address 
specific difficulties around achieving impact. 
One of the sessions, ‘From innovation to 
implementation: the example of vaccines’, 
featured speakers engaged in the whole 
pipeline of vaccine research, from antigen 
discovery and development of a novel 
approach, to the synthesis of glycoconjugate 
vaccines, through to evaluation of vaccine 
effectiveness, policy and advocacy.
Our impact is primarily on improved health 
outcomes achieved through research that 
has led to the development and evaluation 
of new interventions, and has influenced 
health policy at regional, national and global 
levels. In recent years, our research has led 
to changes in policy worldwide, for example in 
the control of HIV, TB and other opportunistic 
infections in southern Africa, to new malaria 
control strategies in countries in West 
Africa, and to changes in syphilis control 
strategies in Brazil, China, Peru, Tanzania, 
Uganda and Zambia.
Excellence and impact
Our impact is primarily 
on improved health 
outcomes achieved through 
research that has led to the 
development and evaluation  
of new interventions, and  
has influenced health policy  
at regional, national and  
global levels”
The public, including patients, benefit 
both directly from our research via better 
interventions, stronger health systems, and 
evidence-based information and indirectly 
through the influence of our research. In the 
UK, the users of our research, and those who 
benefit from it, include several government 
departments, local authorities, the Food 
Standards Agency, Public Health England, 
and the National Health Service, trusts and 
charities (see page 8).
Interdisciplinary collaboration is key to 
facilitating the translation of our research 
results into policy and practice. Our School 
Centres cut across disciplines, departments 
and faculties. For example the Malaria Centre 
fosters a close working relationship between 
parasitologists, geneticists, immunologists 
and population biologists, epidemiologists, 
entomologists, economists and social scientists, 
enabling us to maximise the impact of our 
research on malaria control and prevention.
Over the past five years, we have established 
several new interdisciplinary centres based 
on this successful model. School Centres 
are strongly multi-disciplinary, drawing on a 
diverse range of expertise across faculties 
to address global health challenges.
Evidence into policy case study:  
Txt2stop rolled out as national smoking cessation programme
Smokers are twice as likely to succeed in quitting 
when they receive encouraging text messages. 
The txt2stop study, a major randomised controlled 
trial undertaken by Dr Caroline Free at the School, 
examined the long-term effects of specially-designed 
mobile text messages on 5,800 volunteer participants. 
Published in The Lancet, the study 
was named Research Paper of 
the Year by the Royal College of 
General Practitioners and Novartis, 
and won the Medical Research 
Council and Bupa Foundation 
Healthy Lives Prize. 
Dr Free worked with the Department of Health to roll out the programme 
as a service to smokers across England, and since the launch of the 
service in 2012, more than 50,000 people have received smoking 
cessation support. 42% of participants reported quitting after 4 weeks – 
results which have been widely covered in professional and global 
media, and led to the development of smoking cessation support 
programmes by text message in Sweden, USA, India and Italy, and 
the World Health Organization.
Professor Anne Mills, Vice-Director
The School is also having a major impact in terms of contribution to the public debate on 
a range of issues, with a dramatic increase in media coverage in recent years, including 
many front-page articles in national and global media. We also increased our presence in 
online and social media with our active press Twitter feed gaining over 4,750 followers, 
and Facebook more than doubling to 4,400. Many School researchers are also highly 
networked on social media, with Martin McKee and Ben Goldacre named among the 
most influential health commentators of 2013.
Top 10 media stories and highlights in 2013
•	 Bed	sharing	and	cot	death	risk	for	young	babies
•	 Estimated	premature	deaths	attributable	to	UK	summer	heatwave
•	 John	Snow	bicentenary	symposium	and	exhibition
•	 Malaria	infected	mosquitoes	attracted	to	human	odour
•	 Malaria	Vaccine:	latest	findings	from	the	RTS,S	phase	III	clinical	trial
•	 Medical	tourism	and	the	National	Health	Service
•	 National	Survey	of	Sexual	Attitudes	and	Lifestyles	results
•	 Portable	eye	examination	kit	may	revolutionise	prevention	of	
blindness in low-income countries
•	 UK	Flusurvey	results	from	2012/13	and	launch	with	British	Science	
Association in 2013/14
•	 World	Health	Organization	and	the	School	report	on	global	
prevalence of violence against women
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LSHTM Research Online, our 
open access repository offering 
free public access to our 
research outputs, has grown to 
over 3,700 papers and 1,500 
full‑text abstracts, and we are 
now developing an online data 
repository to facilitate the reuse 
and reanalysis of data and the 
validation of research findings 
both internally and externally.
Media coverage 2011–13
Cari Free awarded Royal College of 
General Practitioners and Novartis 
Research Paper of the Year
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t a time of great change and challenge in the National Health Service and public health 
systems in the UK, we are engaged in a wide range of research programmes and 
projects which are making vital contributions to health outcomes, practice and policy. 
Partnership is key to this work, and in recent years we have developed productive 
and valuable collaborative links with partners in government, the NHS, Public Health 
England, local authorities, Royal Colleges, universities, health policy think-tanks, charities and 
funders including the Wellcome Trust and Cancer Research UK.
We are now home to three Department of 
Health Policy Research Units, partner in a 
fourth, and in 2012 became a partner in the 
National Institute for Health Research School 
for Public Health Research.  
Many other relevant research programmes 
and projects are conducted across the School. 
We published brief summaries of around 
30 of the most recent in March as part 
of our Improving health worldwide series. 
Improving the effectiveness 
of pilot programmes 
Pilot and demonstration programmes are 
vital to inform the early stages of policy 
development. The Policy Innovation Research 
Unit, led by Nicholas Mays, Mark Petticrew 
and Bob Erens at the School, brings together 
health and social care research expertise 
to support and improve evidence-informed 
policy-making in social care and public 
health policy at national level. The Unit is 
Policy Research in Commissioning 
and Healthcare Systems
The new Policy Research Unit in 
Commissioning and the Healthcare 
System, a partnership between the School 
and the Universities of Manchester and 
Kent, works with the Department of 
Health to inform the development of 
policy on commissioning, and how it can 
improve services and access, increase 
effectiveness and respond better to 
patient needs. The Unit also supports the 
Department of Health on policy development 
around Personal Health Budgets, and 
explores the relationship between 
primary care expenditure and outcomes, 
and competition and co-operation as 
strategies in local health systems.
Reducing preventable hospital deaths 
There are almost 12,000 preventable deaths 
in hospitals in England every year due to 
problems with care, however this is less than 
a third of the number previously thought. In 
a study published recently, Helen Hogan and 
Nick Black found the majority of poor care 
associated with preventable deaths was the 
result of poor monitoring of the patient’s 
condition, wrong diagnosis or errors in 
medication or fluid replacement. 
Engagement and voice 
in commissioning 
There is good evidence that patients, 
particularly those with long term conditions, 
benefit from involvement in their own 
care. The Engagement and Voice in 
Commissioning project is funded by the 
National Institute of Health Research to 
investigate how patients and the public 
are involved in local commissioning of 
services, and how health organisations, 
including Clinical Commissioning Groups, 
engage with service users and enable 
their voices to be heard. From 2010 
to 2013, researchers worked with over 
90 patient groups, commissioners, 
health care professionals and individual 
patients in three sites across England, 
focusing on diabetes, neurological 
conditions, and rheumatoid arthritis.
Improving health worldwide: United Kingdom Evidence for decision making 
in local government 
With the abolition of Primary Care Trusts, 
local authorities are now responsible for 
public health, with guidance from NICE, 
and this change will potentially have major 
impacts across England. As partners in 
the NIHR‑funded School for Public Health 
Research, we are working with policy-makers 
and practitioners in local government to 
develop new evaluative research to support 
action on social determinants of health 
across a range of policy sectors including 
regeneration, housing, transport, crime 
and alcohol licensing.
Diversity of providers in the NHS
One of the key aspects of the Health 
and Social Care Act 2013 is the policy of 
broadening the types of provider of healthcare 
to patients to include organisations which 
are not part of the National Health Service 
itself; and to encourage those organisations 
which remain in the National Health Service 
to increase their autonomy by becoming 
National Health Service foundation trusts. 
Pauline Allen, working with colleagues at 
Bristol and Leeds Universities, is undertaking 
a series of studies funded by the National 
Institute for Health Research to examine 
the extent, nature and effects of increasing 
the diversity of providers. 
Healthy transport
The School’s Transport and Health Group 
has recently worked on several high-profile 
studies for the World Health Organization, 
the UK Department for Health and Transport 
for London on road safety and accident 
prevention and urban cycle commuting. 
Results from these and the recent On The 
Buses study of the links between free bus 
travel, health and wellbeing of older people 
and young people received widespread 
coverage throughout 2013. 
There is good evidence 
that patients, 
particularly those with long 
term conditions, benefit from 
involvement in their own care”
Factors affecting lung cancer survival
Lung cancer survival rates in the UK are lower 
than in six comparator countries, according 
to a new international study carried out by 
the Cancer Research UK Survival Group at the 
School. While Sweden had the highest rate of 
one-year survival from the most common form 
of the disease (non-small cell lung cancer) 
at 46%, the UK ranked lowest at just 30%. 
Dietary salt and cardiovascular disease
The number of people in England adding 
salt to food at the table fell 
by more than a quarter in five 
years, according to work by 
Alan Dangour and colleagues 
published in January 2013 in 
the British Journal of Nutrition. 
The researchers found that 
since the salt awareness 
campaign began in 2003, the 
proportion of people reporting 
that they add salt at the table 
dropped from 32% to 23% 
in the following five years.
In recent decades, 
research at the School 
has had a major influence 
on government health policy 
in areas including smoking, 
air pollution and health 
inequalities”
Lord Crisp, former Chief Executive of the 
NHS and Permanent Secretary at the UK 
Department of Health
Olympics and regeneration 
in East London 
What is the long-term legacy for health of 
the London 2012 Games and associated 
urban regeneration? A major five-year project 
is underway to explore whether and how 
social factors for health and well-being 
among local residents have improved as a 
result of new facilities, job opportunities, 
transport infrastructure, green spaces and 
other improvements to promote healthy living. 
Funded by the National Institute for Health 
Research, the Olympics and regeneration in 
East London (ORIEL) project began in 2011, 
with researchers collecting baseline data 
from around 3,000 children aged 11–12 and 
their parents, followed up early in 2013. The 
study focuses on health, well-being, physical 
activity, socioeconomic factors and residents’ 
perceptions of the impact of local changes, 
compared with data from nearby control areas 
outside the Olympic zone. The participants 
will be followed up again early in 2014 and 
will form a cohort for a longitudinal study of 
how socio-economic and health impacts are 
sustained over time. 
UK Flusurvey, now in its fifth year, has been taken 
up by the British Science Association for its 2013/14 
schools participation project
currently evaluating a range of policy pilot 
programmes including: patient choice of 
general practice, cold weather alerts for 
patients with chronic lung disease and 
direct payments in social care. 
United colours of London: 
map developed by 
geoinformation systems 
specialists in the School’s 
Transport and Health Group 
to show the impact of 
changing demographics and 
ethnicity on public health.
 White – British
 White – Non-British
 Black or Black British
 Asian or Asian British
Air pollution and heart attacks
Comparing air pollution data with the records 
of over 150,000 acute coronary patients 
in England and Wales, Cathryn Tonne and 
Paul Wilkinson found that death rates after 
leaving hospital were higher among patients 
who lived in areas with increased exposure 
to particulate matter emissions from road 
traffic and industry. Published in the European 
Heart Journal in February 2013, the results 
show that patients living in London had the 
highest exposure to air pollution levels, and 
that patients from poorer backgrounds were 
more at risk of early death. 
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Peek in practice, working with Maasai communities in Kenya
Diagnostics research 
conducted by School staff in the 
past five years has already led to important 
changes in public health policy and practice 
in many countries. With collaborators in more 
than 100 countries in Africa, Asia and South 
America, we have access to a unique range 
of clinical material for the evaluation of new 
diagnostics, and are particularly well placed to 
study the impact and cost-effectiveness of new 
diagnostic tests in a wide variety of settings. 
Long-life insecticide treated bed nets are one of the most important insect vector control products
advocacy. It supports maternal health 
projects in six countries spanning Africa, 
Asia and the USA with the aim of identifying 
sustainable solutions based on evidence 
from the evaluation.
This year, we also launched Chariot 
Innovations Limited, a wholly-owned subsidiary 
of the School, to focus on commercially-
viable knowledge translation activities. The 
School’s Arthropod Control Product Test Centre 
(Arctec) is now a world-leading independent 
test centre for consultancy and the evaluation 
and development of arthropod pest control 
technologies. It provides laboratory and 
field evaluation of repellent sprays, pumps, 
lotions, impregnated textiles and insecticide-
treated products.
T
he overarching aims of our knowledge 
translation and innovation activities 
are to stimulate take-up of research 
findings and tools, maximise the 
impact and benefit of the School’s 
research through actively expanding areas 
of application, exploiting our expertise and 
innovation, and setting up responsible 
partnerships with industry.
We have major strengths in the genome 
sciences, drug resistance, disease 
transmission and pathogenic mechanisms, 
which enable us to exploit biomedical 
and technology advances and translate 
that knowledge into new drugs, vaccines, 
diagnostic reagents and disease control 
strategies. These innovations are widely 
disseminated through our global networks, 
and partner institutions in disease 
endemic countries are key collaborators 
in this research. 
We are continuing to work with private 
companies. For example, the Merck for 
Mothers Evaluation team, based at the 
School, is assessing the impact of the $500 
million 10-year Merck for Mothers Initiative, 
which focuses on product innovation and 
Our International 
Diagnostics Centre 
works with companies 
and regulatory authorities 
worldwide to reduce barriers  
to market entry for new 
diagnostic tests”
Knowledge translation and innovation
Infectious and parasitic diseases account 
for nearly 20% of all deaths worldwide. 
Although great strides have been made 
to control the ‘big three’ – HIV, malaria 
and tuberculosis – they still claim more 
than four million lives every year, mainly in 
low-income countries. The emergence and 
spread of new and drug-resistant diseases 
is a major and growing global challenge. 
In the UK, thousands die from hospital-
acquired infections, and treatment and 
prevention of antibiotic-resistant strains 
of pathogens costs the National Health 
Service over £1 billion annually.
The Bloomsbury Research Institute is a 
joint venture between the London School 
of Hygiene & Tropical Medicine and 
University College London. Its mission is 
to discover and develop new tools for the 
control and treatment of infection, through 
improved understanding of pathogens 
and the dynamics of infectious disease 
in global populations.
Over the next few years, we aim to bring 
the Institute together under one roof in 
state-of-the-art facilities. This will create 
a centre of excellence for research and 
enhance engagement with industry 
and international networks. It offers 
an innovative model for research and 
training that integrates advances in basic 
science with those in population sciences 
and computational biology, to bring new 
understanding to disease treatment, 
prevention and control.
Professors Polly Roy (above) and Brendan Wren 
were both awarded Wellcome Trust senior 
investigator awards in 2013
Developing a safe Bluetongue 
virus vaccine
Bluetongue is a viral disease of livestock 
spread by midges. Since 1998, outbreaks in 
Europe have killed more than 2 million animals. 
Polly Roy’s research has led to bluetongue 
becoming one of the best understood viruses 
at the structural and molecular levels. This 
has paved the way for improved diagnostics 
and vaccines, and generic applications for 
viral vaccine design. Boehringer Ingelheim 
now produces a bluetongue vaccine based 
on Professor Roy’s research, which will enable 
the creation of several other promising new 
vaccines exploiting virus-like particles as a 
method to produce safe vaccines against 
human and animal viral pathogens.
Using smartphone technology 
for eye health
School researcher Andrew Bastawrous is 
conducting the Nakuru Eye Disease Cohort 
Study – a follow-up of 5,000 participants in the 
Rift Valley of Kenya to assess the incidence of 
the major eye diseases for the first time in an 
African setting. Alongside this study, Andrew 
is developing a Portable Eye Examination 
Kit, known as Peek, which uses adapted 
smartphone technology to identify, diagnose 
and map blindness and visual impairment. This 
has attracted widespread media coverage and 
is now being developed as a key technological 
innovation in eye health diagnosis.
Dr Samuel Assefa recently joined the Department of 
Pathogen Molecular Biology as Research Fellow in 
Population Genomics
Bloomsbury Research Institute
Ann Fazakerley, Director of External Relations 
and Knowledge Transfer
Led by Professor Brendan Wren, researchers 
are using genome sequencing technologies 
to identify pathways and exploit bacterial 
glycosylation systems for glycoengineering 
and novel vaccine design. The research 
group exploits a range of post genome 
research strategies to gain a comprehensive 
understanding of how bacterial pathogens 
function, how they evolve and how they 
interact with their respective hosts. 
More details of this work are on page 17.
Diagnostics are under-valued in global health, 
yet important advances have been made, 
especially in point-of-care diagnostic tests 
for malaria, HIV, syphilis and other infectious 
diseases. These can greatly improve the 
quality of clinical care, and have a major role 
to play in improving surveillance and targeting 
for elimination. Our International Diagnostics 
Centre works with companies and regulatory 
authorities worldwide to reduce barriers to 
market entry for new diagnostic tests.
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 Research by David Conway 
and colleagues shows that 
malaria vector Anopheles 
gambiae mosquitoes 
in Africa, are more 
genetically complex than 
previously thought due to 
interbreeding.  
 Memoranda of 
Understanding signed 
with the University of 
Hong Kong, (below) and 
the National Institute for 
Parasitic Diseases in China.
 UK Flusurvey 2013/14 
launched, with a new 
partnership with the British 
Science Association to 
focus on flu in children, 
with schools nationwide 
now contributing data to 
this vital survey.
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 Programming for Nutrition 
Outcomes, a free, open-
access distance learning 
module, developed with the 
Department for International 
Development to meet 
training needs in countries 
facing a high burden of 
undernutrition; over 15,000 
people from 161 countries 
have already accessed 
the module. 
February
 The bicentenary of John 
Snow, founder of modern 
epidemiology, celebrated 
at the School with a 
symposium series and 
public exhibition of historical 
treasures and new artwork 
inspired by his pioneering 
work and legacy.
 The Lancet Series on 
Europe launched at the 
School: researchers 
led by Martin McKee 
identified many disparities 
in access to services 
and health outcomes.
March
 A gift from Janssen 
Pharmaceutica NV to the 
Centre for Global Mental 
Health established a 
fund for new scholarships 
to support Master’s 
students. A further 
nine scholarships were 
announced in November. 
 Jim McCambridge and 
colleagues found that the 
alcohol industry distorted 
evidence on alcohol control 
measures in order to 
influence Scottish public 
health policy in their favour.
 To mark the 25th 
anniversary of the Department 
of Health Services Research 
and Policy at the School, 
a symposium was held to 
explore how our work has 
helped meet the challenges 
faced by health services 
and systems in the UK and 
abroad, and how our research 
has supported and guided 
changes and reforms.
 A study led by Charlotte 
Watts with the World Health 
Organization and South 
African Medical Research 
Council found that as many 
as one in three women are 
victims of gender violence. 
The report has influenced 
policy and received over 
1,500 pieces of media 
coverage worldwide.
April May June
 Research led by Bob 
Carpenter found that the 
risk of cot death among 
breastfed babies increased 
with bed sharing, even 
when the parents did not 
smoke and the mother had 
not consumed alcohol or 
drugs, prompting the UK 
government to urgently 
examine its guidelines 
on co-sleeping.
 Andy Hall knighted for 
Services to Public Health 
in the Queen’s Birthday 
Honours list. Sir Andy 
studied MSc Epidemiology 
at the School in 1982 
and went on to work 
here for 22 years.
 MARCH Centre for 
Maternal, Adolescent, 
Reproductive and Child 
Health seminar and 
parliamentary briefing for 
the Towards Happier Birth 
Days programme launched to 
improve the health of babies, 
girls and women worldwide.
 Peek, the mobile app and 
clip-on hardware developed 
by Andrew Bastawrous that 
transforms a smartphone 
into a tool capable of carrying 
out eye tests and diagnosing 
problems with vision, was 
tested in Kenya and profiled 
in a BBC exclusive.
 PopART, a major study in 
South Africa and Zambia 
to test a new approach 
to the prevention and 
control of HIV and AIDS in 
Africa was launched led 
by Richard Hayes.
 The School topped 
the table of the world’s 
leading research-focused 
graduate schools published 
by Thomson Reuters and 
Times Higher Education. 
Selected highlights and events
 The School received a 
highly positive review from 
the UK’s Quality Assurance 
Agency for Higher Education, 
which highlighted examples 
of good practice including 
the School’s approach 
to staff development, 
and how research 
excellence and our diverse 
student body support 
educational programmes.
 Ben Armstrong calculated 
around 650 premature 
deaths could be attributed 
to the heatwave in England 
in July 2013. Nick Black 
commissioned by the UK 
Department of Health to 
lead a study into avoidable 
hospital deaths.
 A study led by Kate Walker 
found that publication of 
death rates for individual 
surgeons in England may fail 
to identify poor performance 
in specialties where low 
numbers of key operations 
lead to unreliable results. 
 An evaluation of the 
effectiveness of meningitis 
serogroup A vaccine, 
MenAfriVac, found there had 
been no cases of meningitis 
following a mass vaccination 
campaign in Chad led by 
Brian Greenwood.
 Mobile phone technology, 
including text messaging, 
shown to help people 
adhere to antiretroviral 
therapies and quit smoking, 
in a systematic review led 
by Caroline Free. 
 Memorandum of 
Understanding signed with 
Sichuan University, China.
 London Centre for 
Neglected Tropical Diseases 
launched, a partnership with 
Imperial College London 
and the Natural History 
Museum to tackle diseases 
including blinding trachoma, 
schistosomiasis, soil-
transmitted helminths and 
leishmaniasis, which affect 
more than one billion of the 
world’s poorest people.
 Major international study 
by the Cancer Research 
UK Survival Group at the 
School finds lung cancer 
survival rates in the UK 
are lower than in six 
comparator countries.
 Agreement signed with the 
Kenya Medical Research 
Institute to collaborate 
on training, research 
and capacity building. 
 A new MSc module 
on Pathogen Genomics 
launched, organised 
and taught jointly with 
the Wellcome Trust 
Sanger Institute.
 Peter Piot gave the 
keynote address at the 
World Health Summit 
in Singapore.
 Anne Mills elected a Fellow 
of the Royal Society. 
 The government 
of Ethiopia signed 
a Memorandum of 
Understanding with 
the School, making 
a commitment to 
work closely together 
to strengthen public 
health research and 
training capacity.
 Our Young Scientists 
Programme continued to 
develop throughout the 
year, with 33 students aged 
14–18 from ten schools 
across London undertaking 
two-week independent 
research projects supported 
by academics at the School.
 The China Medical Board 
awarded scholarships 
to Chinese students for 
postgraduate studies at 
the School. We welcomed 
the first students on 
this scheme. 
 Research led by Johanna 
Hanefeld showed that 
foreign patients coming to 
the UK for private medical 
treatment are an important 
source of income for NHS 
Hospital Trusts, and that 
more UK residents currently 
travel abroad for treatment 
than international patients 
travel to the UK.
 The School signed 
Memoranda of 
Understanding with FHI 
360, Universidade de Sao 
Paulo, Brazil and Fundação 
Oswaldo Cruz – Centro 
de Pesquisas Aggeu 
Magalhães, Universidade 
de Pernambuco.
 A new Master’s course in 
One Health, delivered jointly 
with the Royal Veterinary 
College launched to study 
disease at the interface 
between humans, animals 
and the environment.
 Findings from the third 
National Survey of Sexual 
Attitudes and Lifestyles, 
led by Kaye Wellings at the 
School and Dame Anne 
Johnson at UCL, revealed 
how British sexual attitudes 
and behaviour have changed 
in recent decades.
 Aurora leadership 
development initiative 
for women in academia 
launched at the School.
 Students secured 
£80,000 in pledges in the 
first three weeks of our 
Alumni Fund Campaign 
2013/14, putting it on 
course to exceed last year’s 
successful campaign raising 
funds for people, projects 
and partnerships.
 School researchers 
discovered mosquitoes 
infected with malaria 
parasites are significantly 
more attracted to human 
odour than uninfected 
mosquitoes, with important 
implications for vector 
control; the team who made 
the discovery also featured 
in the Wellcome Collection’s 
Who’s the Pest? public 
engagement project.
 The BCG vaccine 
has been found to be 
more effective against 
pulmonary tuberculosis 
than previously thought, 
according to a new 
systematic review led 
by Punam Mangtani.
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Professor John Edmunds
O
ur faculty’s purpose is to 
inform biological understanding 
of diseases and to provide 
evidence for decision-making 
in global public health through 
innovative and rigorous research and 
excellence in teaching. This year, the faculty 
has continued to maintain and develop its 
position at the forefront of both applied 
and methodological research; making 
key contributions to understanding the 
causes of disease, and evaluating new 
ways to improve health.
Randomised controlled trials are the 
gold standard method for determining 
the effectiveness of an intervention, and 
our Clinical Trials Unit continues to lead 
ground-breaking research into the treatment 
of trauma and injuries. Each year, over 
100,000 women die from bleeding after 
childbirth, mostly in low and middle income 
countries. Previous work led by the Unit 
has shown that tranexamic acid (TXA) 
reduces surgical bleeding and death in 
trauma patients. 
The team, headed by Professor Ian Roberts, 
is running a new trial to test the hypothesis 
that tranexamic acid can also reduce 
death from post-partum haemorrhage. 
As of November 2013, the WOMAN trial 
has recruited nearly 10,000 women 
with severe post-partum bleeding in 20 
countries, including large cohorts from 
Sub-Saharan Africa, and is now the biggest 
randomised controlled trial of a treatment 
for post-partum bleeding ever conducted. 
If tranexamic acid is shown to be effective 
in reducing maternal mortality, this will have 
a major impact on clinical care worldwide. 
policy-makers with clear information on 
the comparative effectiveness of health 
systems in managing cancer patients, and 
on what factors, such as stage at diagnosis, 
ethnicity and access to care, may underlie 
the differences in survival within and 
between countries.
New statistical and mathematical advances 
allow for better and more efficient use 
of collected data. One example of this is 
provided by the work of Marc Baguelin and 
colleagues here and at Public Health England. 
They developed a novel statistical framework 
to fit a model of flu transmission to multiple 
longitudinal data sources from the UK. The 
model demonstrated the importance of 
children in spreading flu, and was used to 
guide national immunisation policy. Starting 
in the autumn of 2013, children will now be 
offered an annual flu vaccination in schools 
and nurseries.
Missing data affect both randomised 
controlled trials and observational studies, 
and a key tool for analysing the resulting 
partially observed data is multiple imputation. 
Bob Carpenter and Mike Kenward, who have 
been active in this area for a number of years, 
published a research monograph Multiple 
Imputation and Its Application with Wiley. 
Here they describe advances that overcome 
issues with multilevel data and non-linear 
relationships. Among many applications, this 
methodology was used in the analysis of a 
study which showed bed-sharing is a risk 
factor for sudden unexplained infant death 
(also known as cot death), even in parents 
who do not have other risk factors. This article 
featured in numerous media interviews, and 
has been downloaded over 17,000 times 
since it appeared in May.
Faculty review: Epidemiology and Population Health
Not all clinical trials give an unambiguously 
positive finding. The incidence of tuberculosis 
in South African gold miners is the highest 
in the world, being driven by HIV, silica dust 
and crowded conditions. The Thibela TB 
study was a large-scale cluster randomised 
trial led by Gavin Churchyard of the Aurum 
Institute, an honorary professor in the 
faculty, with Katherine Fielding, Alison Grant 
and other colleagues from the School. The 
study aimed to interrupt TB transmission by 
mass screening and treatment with isoniazid 
preventive therapy. Entire workforces were 
randomly assigned to receive either this 
therapy, or standard TB control. The results, 
to be published early in 2014, showed that 
those mines that adopted the intervention 
had similar incidences and prevalences to 
those that did not. At the individual level it 
appeared that the intervention did reduce TB, 
but this effect was soon lost as individuals 
stopped taking it. 
Intervention trials are not always possible, 
so careful observational studies are often 
required to evaluate the impact of changes 
to health care provision. One of the most 
important such change in recent years is 
the rolling out of antiretroviral therapy for 
HIV positive patients in Africa. Basia Zaba 
and colleagues have analysed data from 
longitudinal population based studies of 
HIV/AIDS in Africa to assess the impact of 
antiretroviral therapy on deaths around the 
time of pregnancy. In a paper published in the 
Lancet, they showed that in their survey of 
over 138,000 women, HIV increased the risk 
of death in pregnant or post-partum women 
by around eight times. The difference is even 
greater in non-pregnant women, due to the 
healthy pregnancy effect – very sick women 
Our Cancer Survival 
Group currently  
involves over 270 cancer 
registries in 66 countries with 
data for around 30 million 
cancer patients”
KEY INFORMATION
Dean of Faculty: Professor John Edmunds
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Department of Infectious Disease Epidemiology  
Head: Professor Carine Ronsmans
 Department of Population Health 
Head: Dr Phil Edwards
 Department of Medical Statistics 
Head: Professor James Carpenter
 Department of Non‑communicable Disease Epidemiology 
Head: Professor Liam Smeeth
Research Degrees Directors: Professor Suzanne Filteau 
and Professor Simon Cousens
Taught Course Director: Craig Higgins
NUMBER OF DOCTORAL STUDENTS 2012/13
Student total: 122 UK/EU: 63 Overseas: 59
Top 5 grants awarded 2012/13
1.  International Initiative for Impact Evaluation (3ie) – Population Effects of Antiretroviral 
Therapy to Reduce HIV Transmission (PopART) Richard Hayes £8.9 million
2.  Wellcome Trust – Wellcome Trust Strategic Award for tuberculosis, HIV and non-
communicable diseases in Malawi Shabbar Jaffar and Moffat Nyirenda £5.6 million
3.  Medical Research Council – Epidemiological and statistical research on health problems 
of developing countries: MRC Tropical Epidemiology Group Richard Hayes £3.9 million
4.  Department of Health – HALT-IT (Haemorrhage Alleviation with Tranexamic acid-Intestinal 
System) Ian Roberts £3.4 million
5.  Wellcome Trust – Population impact of conjugate vaccine on pneumococcal transmission 
and disease in Kenya Anthony Scott £2.0 million
do not become pregnant. Antiretroviral therapy 
has dramatically improved survivorship among 
HIV-infected, non-pregnant women, though 
mortality remains significantly higher than for 
uninfected women. In HIV-infected pregnant 
and post-partum women, the fall in mortality 
with antiretroviral therapy introduction has 
been smaller.
Another key international research programme 
with clear policy implications is CONCORD-2, 
run by our Cancer Research UK Cancer 
Survival Group. This enormous collaboration, 
designed to establish worldwide surveillance 
of cancer survival for the first time, currently 
involves over 270 cancer registries in 66 
countries, with data for around 30 million 
cancer patients. The aim is to achieve robust 
global comparisons of survival trends since 
1995 for 10 cancers in adults and leukaemia 
in children. Even in high-income countries, 
there are wide differences in cancer survival, 
which could be due to factors such as delay 
in diagnosis, unequal access to high-quality 
treatment and the organisation of health 
services. These differences can be even larger 
when comparing across low and middle-
income countries. CONCORD will be the most 
comprehensive analysis of cancer survival to 
date. It will provide national and international 
Thibela tuberculosis project trialled interventions 
among HIV-affected gold miners in South Africa
Manga-style comic created by Ian Roberts to demonstrate the benefits of tranexamic acid in 
emergency medicine
Group activities help young people build nurturing relationships at Sangath, a charity based in Goa, co-founded 
by Vikram Patel, Professor of International Mental Health at the School
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R
esearch on pathogens, infectious 
diseases and interventions 
for disease control involves 
challenges and opportunities 
to integrate new “omic” biology 
and informatics into drug, vaccine and 
diagnostic research and development. 
It is also focused on evaluation and 
implementation into elimination and 
eradication programmes. To meet these 
challenges and opportunities, we have 
made new joint appointments with the 
Sanger Institute and the Crick Institute and 
also the development of the Bloomsbury 
Research Institute (see page 11).
The faculty has led the development of 
a number of School Centres (page 7), 
for example the International Centre 
for Evidence in Disability, TB Centre, 
International Diagnostics Centre, and is a 
key partner in the Centre for Evaluation. 
Our teaching partnerships have also grown 
with the East African Diploma of Tropical 
Medicine and Hygiene, based in Moshi 
Tanzania and Kampala Uganda, now well 
established (with 20 students from Africa 
and 40 international in 2013), and this year 
we have launched a new MSc in One Health 
with the Royal Veterinary College, and a 
new MSc module on Pathogen Genomics, 
organised and taught jointly with members 
of the Wellcome Trust Sanger Institute. 
The Wellcome Trust Bloomsbury Centre 
for Global Health Research 2013 meeting 
included 32 Clinical Fellows, who presented 
the results of their research in 14 countries 
in Africa and Asia and celebrated the 
renewal of the Centre, with Wellcome 
Trust funding, for a further five years. 
Faculty review: Infectious and Tropical Diseases
Whole genome sequencing technologies 
continue to drive research on pathogenesis, 
epidemiology, virulence, and drug and 
vaccine development. Now supported by 
a high-throughput DNA Sequencing Facility 
equipped with an Illumina MiSeq machine, 
this research has offered many new insights 
into drug-resistance in tuberculosis, malaria 
transmission and bacterial pathogenesis. 
New in-vivo imaging technologies, research 
on glycan coupling technology for bacterial 
pathogens and virus-like particles from 
bluetongue virus are enabling productive 
collaborations to be established with the 
private sector, both with pharmaceutical 
companies and the biotech sector, on vaccine, 
diagnostics and drug development. 
Whole genome 
sequencing 
technologies continue  
to drive research on 
pathogenesis, epidemiology, 
virulence, and drug and 
vaccine development”
Malaria intervention trials in Tororo, Uganda, courtesy Helen Allwood, Malaria Capacity Development Consortium 
Clinical interventions and patient care 
are being supported through our research 
innovations. Researchers in our International 
Centre for Eye Health have shown that 
the Portable Eye Examination Kit (Peek), 
a smartphone-based tool, can enable 
comprehensive eye examinations to aid 
the delivery and co-ordination of eye care 
in remote locations. Our continued input, 
through the Artemisinin Combination 
Therapy (ACT) Consortium into malaria 
control, has shown the crucial role of rapid 
diagnostic tests in targeting drugs to those 
who need them, both through public health 
services and in the private sector, in Ghana 
and Uganda.
We are also conducting pioneering work 
on neglected tropical diseases, mainly 
parasitic in origin. Our work continues on the 
Global Atlas of Helminth Infection, disease 
mapping for helminth control, and efforts 
to eliminate trachoma, the most common 
infectious cause of blindness with 21 million 
cases worldwide, have been boosted by 
the launch of the Global Trachoma Mapping 
Project. School researchers are working 
in a consortium with SightSavers and the 
International Trachoma Initiative, Ministries 
of Health, and other NGOs and academic 
partners to complete baseline mapping 
worldwide by 2015.
Professor Simon Croft
Anopheles infected with malaria
KEY INFORMATION
Dean of Faculty: Professor Simon Croft
Staff total: 360 Academic: 255 Professional support: 105
DEPARTMENTS
Department of Clinical Research 
Head: Professor Philippe Mayaud
 Department of Disease Control 
Head: Professor Mark Rowland
 Department of Immunology and Infection 
Head: Dr Colin Sutherland
 Department of Pathogen Molecular Biology 
Head: Professor John Kelly
Research Degrees Director: Dr David Baker
Taught Course Director: Dr Graham Clark
NUMBER OF DOCTORAL STUDENTS 2012/13
Student total: 149 UK/EU: 68 Overseas: 81
Top 5 grants awarded 2012/13
1. Commission of the European Community – TANDEM Hazel Dockrell £5.0 million
2.  Medical Research Council – Seasonal malaria chemoprevention in African children 
Brian Greenwood £4.0 million
3.  UNITAID via World Health Organization – Global Network to Improve Access 
and Quality of HIV Monitoring Technologies Rosanna Peeling £3.0 million
4.  Medical Research Council – Clostridium difficile, intestinal microbiota and host response 
in hospitalised patients Brendan Wren £2.4 million
5.  Commission of the European Community – GENINVADE David Conway £2.4 million
Our interactions with industry are also growing 
in vector control research, with continued 
expansion of Africa-based projects on new 
product development and evaluation, working 
with the Innovative Vector Control Consortium 
and the Pan African Malaria Vector Research 
Consortium. A spin-out company, Arthropod 
Control Product Test Centre (Arctec) is working 
with more than 60 industrial clients on the 
development and evaluation of insect control 
technologies. Another initiative in vector 
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Sanitation in Bangalore with SuperAma intervention
studies, funded through a Biotechnology 
and Biological Sciences Research Council 
Responsive Mode grant, has shown for the 
first time that malaria infected mosquitoes 
respond more to human odour than 
uninfected mosquitoes. 
Research on hygiene and sanitation, also 
in collaboration with industry partners, has 
demonstrated the success of a new approach 
to changing behaviour. The ‘SuperAma’ 
animated video campaign and evaluation 
uses emotional cues such as disgust and 
nurture to encourage mothers to wash their 
hands with soap. With St John’s Research 
Institute Bangalore, this approach significantly 
increased rates of handwashing with soap in 
trials. Hygiene researchers also played a lead 
role in another School study, across faculties, 
which showed, through the first systematic 
review and meta-analysis, the importance of 
water, sanitation and hygiene on childhood 
nutrition and growth. 
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was commissioned by the Department of 
Health to evaluate the Cold Weather Plan for 
England, introduced in 2011. Early findings 
have led Public Health England to review the 
temperature thresholds used to trigger cold 
weather alerts to the NHS, social services 
and other agencies. 
The National Institute for Health and Care 
Excellence contracted the Environmental 
Epidemiology Group to assess evidence on 
the effectiveness of interventions to alleviate 
adverse health effects from cold housing 
and cold weather. The group also won a 
prestigious European Research Council 
grant to investigate the relationship between 
particulate air pollution and risk factors 
for heart disease in India. 
Our faculty also continued to be a leading 
source of advice to the UK NHS. Staff from 
the Department of Health Services Research 
and Policy, in partnership with Royal Colleges 
representing surgeons, obstetricians and 
gynaecologists, advised a number of surgical 
specialties on how best to report clinical 
outcomes for individual clinicians and 
contributed to the national debate on achieving 
greater transparency on the performance of 
health care providers. Staff also advised on the 
introduction of value-based pricing within the 
National Health Service to inform how National 
Institute for Health and Care Excellence will 
decide which treatments are funded by the 
National Health Service and at what price. 
In October, Nick Black, Professor of Health 
Services Research, was awarded a global 
Career Achievement Prize by the International 
Society for Quality in Healthcare, in recognition 
of his work on the use of patient reported 
outcome measures (PROMs). Research with 
collaborators at the University of York, funded 
by the National Institute of Health Research 
looking at the implications for the National 
Health Service of inward and outward medical 
tourism, was published. The largest empirical 
study of medical tourism to date, the findings 
received widespread coverage in professional 
and national media. 
In November, the School held a symposium 
to celebrate 25 years of Health Services 
Research, and assess future challenges. 
Looking ahead, in an exciting new joint venture 
coordinated through UCLPartners, faculty staff 
will play a leading role within the National 
Institute of Health Research Collaboration for 
Leadership in Applied Health Research and 
Care, to carry out applied health research 
within a population of six million people 
living in north and east London and the 
surrounding areas.
Integra launch at the UK House of Lords with 
Susannah Mayhew and President Joyce Banda 
of Malawi
‘SASA!’ is a five-year project to stop violence against women and reduce HIV risk in Uganda. It is led by Raising Voices 
and the Centre for Domestic Violence prevention
T
he mission of the faculty is to 
improve health globally through 
research, teaching and engagement 
in areas of health systems and 
services, health policy, and 
the individual, social and environmental 
determinants of health. We undertake 
cutting-edge research and contribute 
directly to policy in areas of current and 
future importance to public health.
This year has seen a major public focus on 
gender violence: our Gender, Violence and 
Health Centre, within the Department of 
Global Health and Development, led work for 
the Global Burden of Disease in assessing 
the global prevalence and health impacts of 
violence against women and of child sexual 
abuse. The findings, launched with the World 
Health Organization and Medical Research 
Council South Africa with publications in 
Science and The Lancet, showed that 30% of 
partnered women globally have experienced 
violence from a partner. More broadly, the 
Centre’s evidence on effective interventions 
helped inform the growing prevention agenda, 
with staff input into a range of high-level 
consultations. This expertise also led to the 
successful launch of a new short course on 
Researching gender based violence: methods 
and meaning.
It is now beyond doubt that environmental 
change profoundly impacts health and well-
being. Our Environmental Epidemiology Group, 
based within the Department of Social and 
Environmental Health Research, works at the 
forefront of this area, influencing national 
policy. Together with colleagues in the Policy 
Innovation Research Unit in our Department of 
Health Services Research and Policy, the group 
Faculty review: Public Health and Policy
Integrated services, 
provided by trusted and 
competent providers, can be  
a step in the right direction  
to ensuring access to more 
health services for all” 
 
President Joyce Banda speaking at the 
launch of the School’s Integra partnership 
project report at the UK Houses of 
Parliament, March 2013
Professor Richard Smith
At the macro level of climate change, a new 
EU Framework funded project IMPRESSIONS 
(Impacts and Risks from High-End Scenarios: 
Strategies for Innovative Solutions) will focus 
on broader scenarios relating to climate 
change, and a partnership funded by the 
Medical Research Council and Natural 
Environment Research Council with Exeter 
University will create a platform linking 
climate and other environmental data with 
health and well-being data.
Sexual and reproductive health is another 
area in which we are taking a lead. In March, 
researchers from the Anthropology, Politics 
and Policy Group within the Department of 
Global Health and Development launched 
the findings of the Integra Initiative, 
the largest ever evaluation of different 
models of HIV and social and reproductive 
health integration. The study found that 
integration of HIV and reproductive health 
services in Kenya, Malawi and Swaziland 
can lead to better health outcomes and 
service experience, decreased stigma 
and cost savings.
This autumn saw the culmination of work 
by staff within the Department of Social 
and Environmental Health Research on the 
third 10-year UK National Survey of Sexual 
Attitudes and Lifestyles (NATSAL). Over 
15,000 adults aged 16–74 years participated 
in interviews on sexual behaviour, fertility, 
contraceptive use and sex-related diseases. 
Funded by the Medical Research Council 
and the Wellcome Trust, with support from 
the Economic & Social Research Council 
and the Department of Health this is one of 
the largest ever studies of sexual behaviour 
undertaken in a single country. The results, 
published in a special issue of The Lancet 
reveal how sexual behaviour and attitudes in 
Britain have changed in recent decades.
KEY INFORMATION
Dean of Faculty: Professor Richard Smith
Staff total: 286 Academic: 255 Professional support: 31
DEPARTMENTS
Department of Global Health and Development 
Head: Professor Kara Hanson
 Department of Health Services Research and Policy 
Head: Professor Jan van der Meulen
 Department of Social and Environmental Health Research 
Head: Professor Kaye Wellings
Research Degrees Director: Judy Green, Nicki Thorogood (Deputy)
Taught Course Director: Hannah Babad
NUMBER OF DOCTORAL STUDENTS 2012/13
Student total: 135 UK/EU: 72 Overseas: 63
Top 5 grants awarded 2012/13
1.  Department for International Development Asia – Regional Anti-Trafficking Programme  
Cathy Zimmerman £1.5 million
2.  National Institute of Health Research – Using Patient Reported Outcome 
Measures to Assess Quality of Life in Dementia Sarah Smith £995,000
3.  Family Health International USAID – Multi-drug resistant Tuberculosis in Myanmar  
Richard Coker $750,000
4.  National Institute of Health Research – The impact of home energy efficiency 
interventions and winter fuel payments on winter-and cold- related mortality Paul 
Wilkinson £0.6 million 
5.  Rush Foundation – Rethinking and creating fiscal space for HIV through co-investments 
Charlotte Watts £0.6 million
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Our new Tavistock Place buildings are home to the Faculty of Public Health and Policy 
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T
o meet increased demand and 
changing priorities in public and 
global health, our programmes have 
continued to evolve and expand this 
year. Providing joint courses with 
partner institutions in the UK and globally is a 
key strategic goal, and in 2013 we launched 
a new MSc in One Health with the Royal 
Veterinary College, and a new short course in 
vaccinology with the Saw Swee Hock School 
of Public Health at the National University 
of Singapore. In April, we developed a new 
student recruitment strategy, focusing on 
engagement with prospective students and 
applicants, and we secured significant new 
funding for studentships.
Following a comprehensive audit by the 
UK Quality Assurance Agency for Higher 
Education, we received the report in 
January 2013. This confirmed that the 
School ‘meets UK expectations’ in all the 
judgement areas – academic standards, 
quality and enhancement of student learning 
opportunities, and public information about 
the education offered. The report identified 
a number of examples of good practice, 
including our approach to staff development, 
the mechanisms for world-class research 
activity to inform and enhance student 
learning and student peer support networks. 
The Student Representative Council 
participated fully in the review and, as always, 
worked with staff throughout the year to help 
improve the student experience. In addition 
to organising activities around student social, 
welfare, charity and sports activities, the 
Council contributed to developing enhanced 
support in areas such as careers guidance. 
To mark the centenary of the Medical 
Research Council, the School was awarded 
funds to create a competitive award for 
a 6-month postdoctoral fellowship. The 
fellowship was won by Dr Sarah Nogaro, 
building on her PhD research working 
with Dr John Raynes to investigate the 
development of clinical immunity to malaria.
Education: teaching and learning
Professor Sharon Huttly, Dean of Studies
In March, despite snow, we hosted our largest Graduation Day ever
Facts and figures
TOTAL STUDENTS ENROLLED  
2013/14 3925
London-based Master’s and research degrees (all) 1095
Distance learning Master’s students 2830
Adolescent Health in Low & Middle Income Countries
Advanced Course in Epidemiological Analysis
Advanced Stata: Programming and other Techniques to Make 
Your Life Easier
Cancer Survival: Principles, Methods and Applications
Causal Inference in Epidemiology: Recent 
Methodological Developments
Certificate in Pharmacoepidemiology & Pharmacovigilance
Clinical Trials
Diploma in Tropical Medicine & Hygiene
Diploma in Tropical Nursing
LONDON-BASED 
MASTER’S  
DEGREE STUDENTS 
546 669
COURSE
2012/13 2013/14
UK/EU OVERSEAS TOTAL UK/EU OVERSEAS TOTAL
Control of Infectious Diseases 23 18 41 23 21 44
Demography & Health 8 4 12 9 4 13
Epidemiology 29 13 42 28 23 51
Global Mental Health 1 13 7 20 6 19 25
Health Policy, Planning 
& Financing 2 26 23 49 34 37 71
Immunology of Infectious 
Diseases 16 2 18 15 4 19
Medical Entomology for 
Disease Control 6 1 7 3 2 5
Medical Microbiology 17 4 21 10 5 15
Medical Parasitology 17 2 19 7 3 10
Medical Statistics 32 7 39 32 12 44
Molecular Biology of Infectious 
Diseases 5 2 7 6 1 7
Nutrition for Global Health 10 5 15 12 9 21
One Health (Infectious Diseases) 3 – – – 8 0 8
Public Health 83 56 139 114 77 191
Public Health for Eye Care 1 7 8 1 17 18
Public Health in Developing 
Countries 18 23 41 10 29 39
Reproductive & Sexual 
Health Research 10 9 19 16 15 31
Tropical Medicine & 
International Health 17 17 34 24 20 44
Veterinary Epidemiology 3 13 2 15 9 4 13
TOTAL 344 202 546 367 302 669
DOCTORAL DEGREE 
STUDENTS 406 426
FACULTY
2012/13 2013/14
UK/EU OVERSEAS TOTAL UK/EU OVERSEAS TOTAL
Epidemiology and 
Population Health 63 59 122 68 57 125
Infectious and Tropical Diseases 68 81 149 69 80 149
Public Health and Policy 72 63 135 83 69 152
Total 203 203 406 220 206 426
DISTANCE-LEARNING  
STUDENTS 2830
COURSE 2012/13 2013/14
Clinical Trials 314 284
Epidemiology 560 597
Global Health Policy 149 215
Infectious Diseases 382 367
Public Health (all streams together) 1166 1126
Individual modules 234 241
Total 2805 2830
East African Diploma in Tropical Medicine & Hygiene
Epidemiological Evaluation of Vaccines
Factor Analysis & Structural Equation Modelling
High Throughput Sequencing in Disease Studies
Infectious Disease Modelling
Intensive Course in Epidemiology and Medical Statistics
Introduction to Genetic Epidemiology in the GWAS Era
Laboratory Diagnosis of Parasites
Methods for Addressing Selection Bias in Health 
Economic Evaluation
MSc Modules
Pathogen Genomics & Genomic Epidemiology 
of Infectious Disease
Practical Pharmacoepidemiology
Public Health Planning for Hearing Impairment
Researching Gender-based Violence: Methods and Meaning
Statistical Analysis with Missing Data Using Multiple 
Imputation and Inverse Probability Weighting
Systematic Reviews and Meta-Analyses of Health Research
Tropical Ophthalmology
Understanding an Eye Health System in Order to 
Achieve VISION 2020
CONTINUOUS PROFESSIONAL DEVELOPMENT PROGRAMME: SHORT COURSES RUN IN 2012/13  TOTAL PARTICIPANTS 992
TOTAL LONDON-BASED STUDENTS  
2013/14 1095
669
MASTER’S
Type of Study Gender
426
RESEARCH
370
MALE
725
FEMALE
Mode of Study Domicile
806
FULL-TIME 
289 
PART-TIME 470
UK
145
EU
480
OVERSEAS
Fee Status Qualifications
587
UK/EU
508
OVERSEAS
200
MEDICAL 895 
NON-MEDICAL
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The report identified a 
number of examples 
of good practice, including our 
approach to staff development, 
the mechanisms for world-class 
research activity to inform and 
enhance student learning,  
and facilitate student peer 
support networks”
In December, the Higher Education Funding 
Council for England announced new funding 
to support an innovative ‘pre-doctoral’ 
programme in social science for mature 
students at the School and three other 
University of London partners. This will be 
developed and delivered by the Economic 
and Social Science Research Council funded 
Bloomsbury Doctoral Training Centre.
With major changes to the funding 
environment in UK higher education, we 
are planning ahead to meet the needs of 
future generations of postgraduate students. 
This includes working with sector bodies to 
address funding and other challenges. In 
2013/14, we are undertaking a major internal 
review of our education programme to ensure 
it remains globally competitive and relevant 
for students’ future careers.
Research poster showcase event
1 with Institute of Psychiatry, King’s College London   2 with London School of Economicsn   3 with Royal Veterinary College
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Our Values
The School seeks to foster and 
sustain a creative and supportive 
working environment based upon 
an ethos of respect and rigorous 
scientific enquiry.
We are committed to:
•	 Excellence	and	creativity
•	 	Maximising	synergies	
between research, education 
and knowledge translation 
and innovation
•	 	Sharing	expertise	to	strengthen	
capacity globally
•	 	Partnerships	based	on	mutual	
respect and openness
•	 Equity	and	diversity
•	 	Financial	and	environmental	
sustainability
11.2
2012/13 
0
20
20
15
10
5
0
40
60
80
100
120
140
£M
Research grants and contracts
Higher Education Funding Council for England (HEFCE) grants
Tuition fees
Other
EU Commission and other 
government bodies
EU other
UK research councils Industry and commerce outside the EU
Other sources outside the EU
Charities based outside the UK
UK charities
UK government departments 
and health authorities
UK other
2006/07 2007/08 2008/09 2009/10 2010/11 2011/12
2012/13 2006/07 2007/08 2008/09 2009/10 2010/11 2011/12
7.5
14.2
23.3
79.3
18.4
17.7
14.3
8.6
4.7
1.9
1.2
1.0
125.1
Total (£ million)
11.2
2012/13 
0
20
20
15
10
5
0
40
60
80
100
120
140
£M
Research grants and contracts
Higher Education Funding Council for England (HEFCE) grants
Tuition fees
Other
EU Commission and other 
government bodies
EU other
 research councils Industry and commerce outside the EU
Other sources outside the E
Charities based outside the UK
charities
UK government departments 
and health authorities
UK other
2006/07 2007/08 2008/09 2009/10 2010/11 2011/12
2012/13 2006/07 2007/08 2008/09 2009/10 2010/11 2011/12
7.5
14.2
23.3
79.3
8 4
7 7
14.3
8.6
4 7
1.9
1.2
1.0
125.1
Total (£ million)
Research income has increased 
over recent years and represents 
63% of our total income, 
amongst the highest proportion 
of any UK Higher Education 
Institution. School staff have 
been successful in generating 
research grant income, with an 
above average success rate for 
UK research council funding. In 
addition, the School has a broad 
portfolio of funders, including 
large charitable organisations 
such as the Wellcome Trust 
and the Bill and Melinda Gates 
Foundation, the UK Research 
Council and government 
departments, the USA’s National 
Institute for Health, the European 
Union, industry, small charities 
and individual donors.
The School’s research 
encompasses a spectrum 
from fundamental laboratory 
research in infectious diseases 
and studies of disease 
causation, through development 
and assessment of novel 
interventions and services, to 
advising on implementation in 
real life settings of interventions, 
service and system reforms, 
and evaluation that informs 
policy and practice.
Income from all sources 2006/07 to 2012/13
Research income: grants and contracts
People and resources
We are developing the programme to meet 
individual training and our Postgraduate 
Certificate in Learning and Teaching (PGCILT) is 
accredited by the Higher Education Academy. 
We support learning and transferable skills 
development for early career researchers.
The School is an equal opportunities employer, 
and part of the Athena SWAN award scheme 
to promote women in Science. In 2013, 
two faculties secured Bronze departmental 
awards, in addition to the Bronze Award for 
the School last year. We are currently working 
towards achieving Silver awards across the 
School in 2014.
In October 2013, we appointed four members 
of staff to the Aurora programme, the 
leadership development initiative for women, 
run by the Leadership Foundation for Higher 
The School’s 
success is founded 
on its committed staff, 
its collaborators and the 
synergies that result from 
these interactions”
W
e aim to recruit, manage, 
develop and retain excellent 
staff based in the UK and 
elsewhere to deliver the School’s 
mission. We have also made 
great progress in improving the School’s 
management and administration. 
The School embraces and values the diversity 
of its staff and student population and 
seeks to promote equality as an essential 
element in contribution to the improvement 
of health worldwide. Our Talent and Educational 
Development Programme provides a range of 
training workshops, seminars, online courses and 
other personal and professional development 
opportunities for staff across the School. 
Education. Aurora aims to enable a wider 
range of women in academic and professional 
roles to become future leaders, developing 
their skills and advancing their institutions.
In November, the School was one of the first 
Higher Education Institutions to be accredited 
as Living Wage Employers by the Living Wage 
Foundation. To be accredited, an employer 
must ensure all directly-employed staff and 
contractors receive the Living Wage, which 
is calculated according to the basic cost of 
living (currently £8.80 in London). This award 
recognises our commitment to fair pay.
This year, the School joined the Stonewall 
Diversity Champion programme, Britain’s 
good practice employers’ forum on 
sexual orientation. We will be working 
with Stonewall and other employers on 
the programme to ensure that we are a 
workplace of good practice.
The School is a certified user of the Two Ticks 
Disability Symbol Scheme, and is committed 
to employing people with disabilities.
Richard Benson, Secretary and Director of 
Resources and Planning (left) and Andrew Young, 
Chief Operating Officer (right)
Our strategy 2012–17
The purpose of the Strategy is to provide 
a framework to guide decisions focused on 
School-wide priorities over the next five years. 
The strategy enables the School to:
•	 Identify	key	areas	of	development	and	
investment, appointments, research 
directions and collaborations, education 
programmes and capital projects
•	 Frame	communication	with	key	
stakeholders and audiences
The Strategy document can be downloaded from 
www.lshtm.ac.uk/aboutus/introducing/ mission
•	 Prioritise	development	of	facilities	and	
support services to optimise efficiency 
and effectiveness
•	 Ensure	the	School’s	reputation	continues	to	
grow globally, helping us to fulfil our vision 
and mission
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Management and governance
Patron
HRH Prince Philip  
Duke of Edinburgh KG KT
Design: Ball Design Consultancy
Honorary Fellows
An Honorary Fellowship is the 
School’s most prestigious 
honour and is conferred 
on those people who have 
rendered exceptional service 
to the School or have attained 
exceptional distinction in 
any of the subjects taught 
in the School.
Valerie Beral
David Bradley
André Capron
Jimmy Carter
Baroness Chalker Of Wallasey
Manuel Dayrit
John Robert Evans
Sir Richard Feachem
William Foege
Tedros Adhanom Ghebreyesus
Tore Godal
John Godfrey
Coluthur Gopalan
Sir Brian Greenwood
Demissie Habte
Donald Henderson
Ralph Lainson
Robert Logan
Adetokunbo Lucas
Dame Sally Macintyre
Halfdan Mahler
Tony McMichael
David Nabarro
Sadako Ogata
Sir Eldryd Parry
Sir Richard Peto
K Srinath Reddy
Amartya Sen
John Hilary Smith
Alfred Sommer
Robin Weiss
Peter Williams
Council (At 1 December 2013)
Chair: Sir Tim Lankester KCB MA (Camb) MA (Yale) 
Deputy Chair: Dr Diana Walford  
CBE MA BSc MSc MD FRCP FRCPath FFPH FRS
Ex‑Officio Members
Mr Dino Motti, Chair, Student 
Representative Council 
Dr David Jolliffe CB FRCP (Chairman of Court) 
Professor Baron Peter Piot CMG MD PhD  
FRCP FMedSci (Director)
Appointed by the Secretary 
of State for Health
Dr Simon Tanner BM MSc MRCGP FFPH 
(to 31.03.13)
Appointed by the Secretary of State 
for International Development
Dr Andrée Carter PhD FISoilSci MCIWEM
Appointed by the University of London
Professor Nicholas Barber BPharm PhD MRPharmS 
FRSM (to 31.08.13)
Independent Appointees
Mr Kash Chandarana BSc ACA 
Ms Ann Grant BA, MSc 
Sir Tim Lankester KCB MA (Camb) MA (Yale) 
Mr John O’Donnell 
Mr Jan Pethick (Honorary Treasurer and 
Chairman of Planning & Finance Committee) 
Mr Sushil Premchand BA, FCA 
Mr Jonathan Roper MA (Cantab) 
Professor John Stephenson BSc PhD CBiol FSB 
Dr Diana Walford CBE MA BSc MSc MD FRCP  
FRCPath FFPH
Academic Staff Members
Ms Lynda Clarke BSc MSc 
Dr Kara Hanson BA MPhil ScD  
Professor John Kelly BSc PhD 
Professor Eleanor Riley BSc BVSc PhD 
Professor David Ross MA BM BCh MSc PhD DLSHTM 
Professor Paul Wilkinson BSc BM BCh MRCP (UK) MSc
Professional Support Staff Members
Mr Dan Arthur BSc
Secretary & Director of 
Resources & Planning
Mr Richard Benson BA
Organisational structure from December 2013
Information Technology Services 
Jon Faulkner
Human Resources 
Johanna Brake-Oakes
Distance Education & Professional 
Development Office 
Sue Horrill
Development 
William Friar
Communications 
Patrick Wilson
Finance 
John Garnham
Research Management 
Chris Andrews & Sue Gammerman 
& Michael Robinson
Legal 
Jens Hinricher
Planning & Governance 
Hilary Hunter
Research Governance  
& Quality 
Patricia Henley
Resources & Planning 
Secretary and Director:  
Richard Benson
Library & Archive Services 
Caroline Lloyd
Procurement 
Keith Flanders
Estates  
Nick Jones
Health & Safety 
Heidi Alderton
Registry 
James Brown & 
 Christopher McMahon
Professional Support Services 
Chief Operating Officer:  
Andrew Young
E-Learning 
 Trevor Manning
Student Advice &  
Counselling Service 
 Emma Nabavian
Vice-Director for Academic Affairs 
Anne Mills
Advisor on Africa 
Hazel Dockrell
Executive Officer 
Frances Fowler
Faculty of Epidemiology 
& Population Health 
Dean: John Edmunds
Department of Infectious 
Disease Epidemiology 
Carine Ronsmans
Department of Medical Statistics 
James Carpenter
Department of Non-Communicable 
Disease Epidemiology 
Liam Smeeth
Taught Course Director 
Craig Higgins
Department of Nutrition & Public 
Health Intervention Research 
Phil Edwards
Faculty Research 
Degrees Directors 
Suzanne Filteau & 
Simon Cousens
Department of Global 
Health & Development 
Kara Hanson
Department of Health Services 
Research & Policy  
Jan van der Meulen
Department of Social &  
Environmental Health Research 
Tim Rhodes
Taught Course Director 
Hannah Babad
Faculty Research  
Degrees Director 
Judith Green and  
Nicki Thorogood (Deputy)
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